Physician perspectives and clinical evidence
Hear from your peers on the potential of AI in GI practice
Transformation through the power of AI
Articles and clinical evidence about artificial intelligence in gastroenterology
Societal implications of AI in GI
AI is evolving quickly, and it has the potential to advance medicine to optimize identification and treatment of health issues for patients. Yet in gastroenterology — as in other fields both inside and outside health care — there’s an obligation for AI developers and users to understand how to employ the technology ethically.
AI in GI:
the basics
When we talk about artificial intelligence (AI) in gastroenterology, we are often talking about “smart” machines and software that can act as a secondary observer for healthcare professionals. One application is to help increase the ability to detect and diagnose suspicious lesions. But what are these different systems, and how do they work?
Why AI in GI?
Why now?
For the first time, artificial intelligence (AI) has been integrated seamlessly into colonoscopy. This advancement might help endoscopists improve adenoma detection rates (ADR) which may help prevent colorectal cancer (CRC). But what does AI mean in this context, and why is it important now?
Adenoma detection rate and risks of colorectal cancer
Adenoma detection rate (ADR) is vital for evaluating an endoscopist’s ability to find adenomas.
The efficacy of real-time computer-aided detection of colorectal neoplasia
Endoscopists evaluate the clinical application and increase of ADR with AI-assisted colonoscopy.
New artificial intelligence system for gastroenterologists
The first validation study versus experienced endoscopists for colorectal polyp detection using ai-assisted colonoscopy.
Clinical relevance to assess distribution of false positives
The evaluation of computer-aided detection associated to the prevalence of false positives and impact to physician withdraw time in clinical practice.
Expert impressions of artificial intelligence in gastroenterology
Listen to experts discuss the role of artificial intelligence in clinical practice.
Integrating AI into practice - (28:14)
Physicians discuss AI in GI considerations - (27:14)
Artificial intelligence in clinical practice - (00:56)
Adenoma detection rate in a colonoscopy - (02:26)
Clinical perspectives of AI in GI
Read the studies below to learn about the broad applications of artificial intelligence in gastroenterology.
The additional evidence is for educational purposes on the topic of AI to study various considerations based on research and physician opinion. Some of the AI applications discussed in this section do not reflect Medtronic supported technology.
The future of AI in GI is now
Read about the introduction to AI terminology and the potential impact to GI care.
Demystifying AI in gastroenterology
Learn how to distinguish from various applications of AI advancements in healthcare.
Gastrointestinal society connection
American Gastroenterological Association (AGA)
The AGA Center for GI Innovation and Technology supports innovation and the development of new technology in gastroenterology, hepatology, nutrition and obesity by guiding medical device and therapeutics innovators through the technology development and adoption process.
American Society of Gastroenterology (ASGE)
The American Society for Gastrointestinal Endoscopy is helping to establish and integrate the optimal use and application of AI technology in the GI space. This effort represents ASGE's long-standing commitment in applying new and advanced technology to deliver improved care of GI patients.
Position statement on priorities for artificial intelligence in GI endoscopy: A report by the ASGE task force
Artificial intelligence (AI) in GI endoscopy holds tremendous promise to augment clinical performance, establish better treatment plans, and improve patient outcomes.
Explore the possibilities of artificial intelligence
Together, Medtronic and ASGE are advancing education to
shape the future of gastroenterology.
Disclaimer: All content from healthcare professionals is their individual conclusions, unless otherwise cited. All speaker or author engagement for content is noted to acknowledge funding from Covidien LP, a Medtronic company, for any consulting engagement.